Literature DB >> 25172101

SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Nuzhat N Kabir1, Jianmin Sun, Lars Rönnstrand, Julhash U Kazi.   

Abstract

The suppressors of cytokine signaling (SOCS) are well-known negative regulators of cytokine receptor signaling. SOCS6 is one of eight members of the SOCS family of proteins. Similar to other SOCS proteins, SOCS6 consists of an uncharacterized extended N-terminal region followed by an SH2 domain and a SOCS box. Unlike other SOCS proteins, SOCS6 is mainly involved in negative regulation of receptor tyrosine kinase signaling. SOCS6 is widely expressed in many tissues and is found to be downregulated in many cancers including colorectal cancer, gastric cancer, lung cancer, ovarian cancer, stomach cancer, thyroid cancer, hepatocellular carcinoma, and pancreatic cancer. SOCS6 is involved in negative regulation of receptor signaling by increasing degradation mediated by ubiquitination of receptors or substrate proteins and induces apoptosis by targeting mitochondrial proteins. Therefore, SOCS6 turns out as an important regulator of survival signaling and its activity is required for controlling receptor tyrosine kinase signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172101     DOI: 10.1007/s13277-014-2542-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  54 in total

1.  Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells.

Authors:  D Fang; H Y Wang; N Fang; Y Altman; C Elly; Y C Liu
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

2.  Cloning and characterization of novel CIS family genes.

Authors:  M Masuhara; H Sakamoto; A Matsumoto; R Suzuki; H Yasukawa; K Mitsui; T Wakioka; S Tanimura; A Sasaki; H Misawa; M Yokouchi; M Ohtsubo; A Yoshimura
Journal:  Biochem Biophys Res Commun       Date:  1997-10-20       Impact factor: 3.575

3.  The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.

Authors:  J Sun; S Mohlin; A Lundby; J U Kazi; U Hellman; S Påhlman; J V Olsen; L Rönnstrand
Journal:  Oncogene       Date:  2013-11-11       Impact factor: 9.867

Review 4.  Protein kinase C (PKC) as a drug target in chronic lymphocytic leukemia.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Med Oncol       Date:  2013-10-31       Impact factor: 3.064

5.  Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin.

Authors:  Sassan Hafizi; Filiz Alindri; Roger Karlsson; Björn Dahlbäck
Journal:  Biochem Biophys Res Commun       Date:  2002-12-20       Impact factor: 3.575

6.  miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.

Authors:  Qiong Wu; Guanhong Luo; Zhiping Yang; Fei Zhu; Yanxin An; Yongquan Shi; Daiming Fan
Journal:  FEBS Lett       Date:  2014-05-05       Impact factor: 4.124

7.  Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans.

Authors:  Alexander S Banks; Jianze Li; Lisa McKeag; Marta L Hribal; Masaki Kashiwada; Domenico Accili; Paul B Rothman
Journal:  J Clin Invest       Date:  2005-08-25       Impact factor: 14.808

Review 8.  The suppressors of cytokine signalling (SOCS).

Authors:  B T Kile; W S Alexander
Journal:  Cell Mol Life Sci       Date:  2001-10       Impact factor: 9.261

9.  Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

Authors:  Walid Sasi; Wen G Jiang; Anup Sharma; Kefah Mokbel
Journal:  BMC Cancer       Date:  2010-04-30       Impact factor: 4.430

10.  Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.

Authors:  Xinyu Qiu; Jianyong Zheng; Xiaodong Guo; Xingchun Gao; Hui Liu; Yanyang Tu; Yongsheng Zhang
Journal:  Mol Cell Biochem       Date:  2013-03-11       Impact factor: 3.396

View more
  19 in total

Review 1.  IFNs-signaling effects on lung cancer: an up-to-date pathways-specific review.

Authors:  Vasiliki Galani; Michalis Kastamoulas; Anna Varouktsi; Evangeli Lampri; Antigoni Mitselou; Dimitrios L Arvanitis
Journal:  Clin Exp Med       Date:  2016-07-14       Impact factor: 3.984

2.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 3.  Role of SRC-like adaptor protein (SLAP) in immune and malignant cell signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2015-03-13       Impact factor: 9.261

4.  Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6.

Authors:  Jian Ma; Li-Yun Xu; Qiu-Hong Sun; Xiao-Yu Wan
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

5.  Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML.

Authors:  Mohammed Dany; Salih Gencer; Rose Nganga; Raquela J Thomas; Natalia Oleinik; Kyla D Baron; Zdzislaw M Szulc; Peter Ruvolo; Steven Kornblau; Michael Andreeff; Besim Ogretmen
Journal:  Blood       Date:  2016-08-18       Impact factor: 22.113

6.  Circ_0085289 Alleviates the Progression of Periodontitis by Regulating let-7f-5p/SOCS6 Pathway.

Authors:  Wenwen Du; Li Wang; Zhen Liao; Juan Wang
Journal:  Inflammation       Date:  2021-03-12       Impact factor: 4.092

7.  Expression of GADS enhances FLT3-induced mitogenic signaling.

Authors:  Rohit A Chougule; Eugenia Cordero; Sausan A Moharram; Kristian Pietras; Lars Rönnstrand; Julhash U Kazi
Journal:  Oncotarget       Date:  2016-03-22

8.  MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.

Authors:  Xinying Xue; Yuxia Liu; Yong Wang; Mingming Meng; Kaifei Wang; Xuefeng Zang; Sheng Zhao; Xiaohua Sun; Lei Cui; Lei Pan; Sanhong Liu
Journal:  Oncotarget       Date:  2016-12-20

9.  Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication.

Authors:  Jinmei Liu; Yurong Zheng; Ju Gao; Guimei Zhu; Kun Gao; Wenzhen Zhang; Fangyan Shi; Qing Zhang
Journal:  Onco Targets Ther       Date:  2017-03-29       Impact factor: 4.147

10.  FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.

Authors:  Rohit A Chougule; Julhash U Kazi; Lars Rönnstrand
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.